[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Preventive Asthma Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 78 pages | ID: P43637AC9243EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The main side effect is heartbeat. Commonly used are salbutamol (Salbutamol), terbutaline (Terbutaline) and so on.

This report contains market size and forecasts of Preventive Asthma Drug in global, including the following market information:

Global Preventive Asthma Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Preventive Asthma Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Preventive Asthma Drug companies in 2021 (%)

The global Preventive Asthma Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Somatostatin Analogs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Preventive Asthma Drug include Xiaflex, Novartis AG, Roche, Molecular Insight Pharmaceuticals and Callisto Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preventive Asthma Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Preventive Asthma Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Preventive Asthma Drug Market Segment Percentages, by Type, 2021 (%)
  • Somatostatin Analogs
  • Targeted Therapy
  • Chemotherapy
Global Preventive Asthma Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Preventive Asthma Drug Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Clinics
  • Oncology Centres
Global Preventive Asthma Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Preventive Asthma Drug Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Preventive Asthma Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Preventive Asthma Drug revenues share in global market, 2021 (%)

Key companies Preventive Asthma Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Preventive Asthma Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Xiaflex
  • Novartis AG
  • Roche
  • Molecular Insight Pharmaceuticals
  • Callisto Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Preventive Asthma Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Preventive Asthma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PREVENTIVE ASTHMA DRUG OVERALL MARKET SIZE

2.1 Global Preventive Asthma Drug Market Size: 2021 VS 2028
2.2 Global Preventive Asthma Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Preventive Asthma Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Preventive Asthma Drug Players in Global Market
3.2 Top Global Preventive Asthma Drug Companies Ranked by Revenue
3.3 Global Preventive Asthma Drug Revenue by Companies
3.4 Global Preventive Asthma Drug Sales by Companies
3.5 Global Preventive Asthma Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Preventive Asthma Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Preventive Asthma Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Preventive Asthma Drug Players in Global Market
  3.8.1 List of Global Tier 1 Preventive Asthma Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Preventive Asthma Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Preventive Asthma Drug Market Size Markets, 2021 & 2028
  4.1.2 Somatostatin Analogs
  4.1.3 Targeted Therapy
  4.1.4 Chemotherapy
4.2 By Type - Global Preventive Asthma Drug Revenue & Forecasts
  4.2.1 By Type - Global Preventive Asthma Drug Revenue, 2017-2022
  4.2.2 By Type - Global Preventive Asthma Drug Revenue, 2023-2028
  4.2.3 By Type - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Preventive Asthma Drug Sales & Forecasts
  4.3.1 By Type - Global Preventive Asthma Drug Sales, 2017-2022
  4.3.2 By Type - Global Preventive Asthma Drug Sales, 2023-2028
  4.3.3 By Type - Global Preventive Asthma Drug Sales Market Share, 2017-2028
4.4 By Type - Global Preventive Asthma Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Preventive Asthma Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
  5.1.4 Oncology Centres
5.2 By Application - Global Preventive Asthma Drug Revenue & Forecasts
  5.2.1 By Application - Global Preventive Asthma Drug Revenue, 2017-2022
  5.2.2 By Application - Global Preventive Asthma Drug Revenue, 2023-2028
  5.2.3 By Application - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Preventive Asthma Drug Sales & Forecasts
  5.3.1 By Application - Global Preventive Asthma Drug Sales, 2017-2022
  5.3.2 By Application - Global Preventive Asthma Drug Sales, 2023-2028
  5.3.3 By Application - Global Preventive Asthma Drug Sales Market Share, 2017-2028
5.4 By Application - Global Preventive Asthma Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Preventive Asthma Drug Market Size, 2021 & 2028
6.2 By Region - Global Preventive Asthma Drug Revenue & Forecasts
  6.2.1 By Region - Global Preventive Asthma Drug Revenue, 2017-2022
  6.2.2 By Region - Global Preventive Asthma Drug Revenue, 2023-2028
  6.2.3 By Region - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Preventive Asthma Drug Sales & Forecasts
  6.3.1 By Region - Global Preventive Asthma Drug Sales, 2017-2022
  6.3.2 By Region - Global Preventive Asthma Drug Sales, 2023-2028
  6.3.3 By Region - Global Preventive Asthma Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Preventive Asthma Drug Revenue, 2017-2028
  6.4.2 By Country - North America Preventive Asthma Drug Sales, 2017-2028
  6.4.3 US Preventive Asthma Drug Market Size, 2017-2028
  6.4.4 Canada Preventive Asthma Drug Market Size, 2017-2028
  6.4.5 Mexico Preventive Asthma Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Preventive Asthma Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Preventive Asthma Drug Sales, 2017-2028
  6.5.3 Germany Preventive Asthma Drug Market Size, 2017-2028
  6.5.4 France Preventive Asthma Drug Market Size, 2017-2028
  6.5.5 U.K. Preventive Asthma Drug Market Size, 2017-2028
  6.5.6 Italy Preventive Asthma Drug Market Size, 2017-2028
  6.5.7 Russia Preventive Asthma Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Preventive Asthma Drug Market Size, 2017-2028
  6.5.9 Benelux Preventive Asthma Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Preventive Asthma Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Preventive Asthma Drug Sales, 2017-2028
  6.6.3 China Preventive Asthma Drug Market Size, 2017-2028
  6.6.4 Japan Preventive Asthma Drug Market Size, 2017-2028
  6.6.5 South Korea Preventive Asthma Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Preventive Asthma Drug Market Size, 2017-2028
  6.6.7 India Preventive Asthma Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Preventive Asthma Drug Revenue, 2017-2028
  6.7.2 By Country - South America Preventive Asthma Drug Sales, 2017-2028
  6.7.3 Brazil Preventive Asthma Drug Market Size, 2017-2028
  6.7.4 Argentina Preventive Asthma Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Preventive Asthma Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Preventive Asthma Drug Sales, 2017-2028
  6.8.3 Turkey Preventive Asthma Drug Market Size, 2017-2028
  6.8.4 Israel Preventive Asthma Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Preventive Asthma Drug Market Size, 2017-2028
  6.8.6 UAE Preventive Asthma Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Xiaflex
  7.1.1 Xiaflex Corporate Summary
  7.1.2 Xiaflex Business Overview
  7.1.3 Xiaflex Preventive Asthma Drug Major Product Offerings
  7.1.4 Xiaflex Preventive Asthma Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Xiaflex Key News
7.2 Novartis AG
  7.2.1 Novartis AG Corporate Summary
  7.2.2 Novartis AG Business Overview
  7.2.3 Novartis AG Preventive Asthma Drug Major Product Offerings
  7.2.4 Novartis AG Preventive Asthma Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Novartis AG Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Preventive Asthma Drug Major Product Offerings
  7.3.4 Roche Preventive Asthma Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Roche Key News
7.4 Molecular Insight Pharmaceuticals
  7.4.1 Molecular Insight Pharmaceuticals Corporate Summary
  7.4.2 Molecular Insight Pharmaceuticals Business Overview
  7.4.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Major Product Offerings
  7.4.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Molecular Insight Pharmaceuticals Key News
7.5 Callisto Pharmaceuticals
  7.5.1 Callisto Pharmaceuticals Corporate Summary
  7.5.2 Callisto Pharmaceuticals Business Overview
  7.5.3 Callisto Pharmaceuticals Preventive Asthma Drug Major Product Offerings
  7.5.4 Callisto Pharmaceuticals Preventive Asthma Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Callisto Pharmaceuticals Key News

8 GLOBAL PREVENTIVE ASTHMA DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Preventive Asthma Drug Production Capacity, 2017-2028
8.2 Preventive Asthma Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Preventive Asthma Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PREVENTIVE ASTHMA DRUG SUPPLY CHAIN ANALYSIS

10.1 Preventive Asthma Drug Industry Value Chain
10.2 Preventive Asthma Drug Upstream Market
10.3 Preventive Asthma Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Preventive Asthma Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Preventive Asthma Drug in Global Market
Table 2. Top Preventive Asthma Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Preventive Asthma Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Preventive Asthma Drug Revenue Share by Companies, 2017-2022
Table 5. Global Preventive Asthma Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Preventive Asthma Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Preventive Asthma Drug Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Preventive Asthma Drug Product Type
Table 9. List of Global Tier 1 Preventive Asthma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preventive Asthma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Preventive Asthma Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Preventive Asthma Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Preventive Asthma Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Preventive Asthma Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Preventive Asthma Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Preventive Asthma Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Preventive Asthma Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Preventive Asthma Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Preventive Asthma Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Preventive Asthma Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Preventive Asthma Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Preventive Asthma Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Preventive Asthma Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Preventive Asthma Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Preventive Asthma Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Preventive Asthma Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Preventive Asthma Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Preventive Asthma Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Preventive Asthma Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Preventive Asthma Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Preventive Asthma Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Preventive Asthma Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Preventive Asthma Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Preventive Asthma Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Preventive Asthma Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Preventive Asthma Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Preventive Asthma Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Preventive Asthma Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Preventive Asthma Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Preventive Asthma Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Preventive Asthma Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Preventive Asthma Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Preventive Asthma Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Preventive Asthma Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Preventive Asthma Drug Sales, (K Units), 2023-2028
Table 46. Xiaflex Corporate Summary
Table 47. Xiaflex Preventive Asthma Drug Product Offerings
Table 48. Xiaflex Preventive Asthma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis AG Corporate Summary
Table 50. Novartis AG Preventive Asthma Drug Product Offerings
Table 51. Novartis AG Preventive Asthma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Preventive Asthma Drug Product Offerings
Table 54. Roche Preventive Asthma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Molecular Insight Pharmaceuticals Corporate Summary
Table 56. Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Offerings
Table 57. Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Callisto Pharmaceuticals Corporate Summary
Table 59. Callisto Pharmaceuticals Preventive Asthma Drug Product Offerings
Table 60. Callisto Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Preventive Asthma Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Preventive Asthma Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Preventive Asthma Drug Production by Region, 2017-2022 (K Units)
Table 64. Global Preventive Asthma Drug Production by Region, 2023-2028 (K Units)
Table 65. Preventive Asthma Drug Market Opportunities & Trends in Global Market
Table 66. Preventive Asthma Drug Market Drivers in Global Market
Table 67. Preventive Asthma Drug Market Restraints in Global Market
Table 68. Preventive Asthma Drug Raw Materials
Table 69. Preventive Asthma Drug Raw Materials Suppliers in Global Market
Table 70. Typical Preventive Asthma Drug Downstream
Table 71. Preventive Asthma Drug Downstream Clients in Global Market
Table 72. Preventive Asthma Drug Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Preventive Asthma Drug Segment by Type
Figure 2. Preventive Asthma Drug Segment by Application
Figure 3. Global Preventive Asthma Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preventive Asthma Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preventive Asthma Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Preventive Asthma Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Preventive Asthma Drug Revenue in 2021
Figure 9. By Type - Global Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Preventive Asthma Drug Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Preventive Asthma Drug Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 19. US Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 24. Germany Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 33. China Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 40. Brazil Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Preventive Asthma Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Preventive Asthma Drug Sales Market Share, 2017-2028
Figure 44. Turkey Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Preventive Asthma Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Preventive Asthma Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Preventive Asthma Drug by Region, 2021 VS 2028
Figure 50. Preventive Asthma Drug Industry Value Chain
Figure 51. Marketing Channels


More Publications